204 related articles for article (PubMed ID: 37454595)
41. The Difference between White and Red Ginseng: Variations in Ginsenosides and Immunomodulation.
He M; Huang X; Liu S; Guo C; Xie Y; Meijer AH; Wang M
Planta Med; 2018 Aug; 84(12-13):845-854. PubMed ID: 29925101
[TBL] [Abstract][Full Text] [Related]
42. Treatment of the cardiac hypertrophic response and heart failure with ginseng, ginsenosides, and ginseng-related products.
Karmazyn M; Gan XT
Can J Physiol Pharmacol; 2017 Oct; 95(10):1170-1176. PubMed ID: 28505464
[TBL] [Abstract][Full Text] [Related]
43. Review of Ginseng Anti-Diabetic Studies.
Chen W; Balan P; Popovich DG
Molecules; 2019 Dec; 24(24):. PubMed ID: 31835292
[TBL] [Abstract][Full Text] [Related]
44. Screening of Potential α-Glucosidase Inhibitors from the Roots and Rhizomes of
Wang HP; Fan CL; Lin ZZ; Yin Q; Zhao C; Peng P; Zhang R; Wang ZJ; Du J; Wang ZB
Molecules; 2023 Feb; 28(5):. PubMed ID: 36903317
[No Abstract] [Full Text] [Related]
45. Ginsenosides: an immunomodulator for the treatment of colorectal cancer.
Qian J; Jiang Y; Hu H
Front Pharmacol; 2024; 15():1408993. PubMed ID: 38939839
[TBL] [Abstract][Full Text] [Related]
46. Use of ginseng in medicine with emphasis on neurodegenerative disorders.
Radad K; Gille G; Liu L; Rausch WD
J Pharmacol Sci; 2006 Mar; 100(3):175-86. PubMed ID: 16518078
[TBL] [Abstract][Full Text] [Related]
47. Panax ginseng components and the pathogenesis of Alzheimer's disease (Review).
Razgonova MP; Veselov VV; Zakharenko AM; Golokhvast KS; Nosyrev AE; Cravotto G; Tsatsakis A; Spandidos DA
Mol Med Rep; 2019 Apr; 19(4):2975-2998. PubMed ID: 30816465
[TBL] [Abstract][Full Text] [Related]
48. Recent advances in ginsenosides against respiratory diseases: Therapeutic targets and potential mechanisms.
Ding L; Qi H; Wang Y; Zhang Z; Liu Q; Guo C; Liu J; Chen Z; Li J; Chen J; Huang Q; Zhao D; Wang Z; Li X
Biomed Pharmacother; 2023 Feb; 158():114096. PubMed ID: 36502752
[TBL] [Abstract][Full Text] [Related]
49. Antiviral Potential of the Genus
Zhang Y; Zhong X; Xi Z; Li Y; Xu H
J Ginseng Res; 2023 Mar; 47(2):183-192. PubMed ID: 36926608
[TBL] [Abstract][Full Text] [Related]
50. Drought Resistance and Ginsenosides Biosynthesis in Response to Abscisic Acid in
Kong L; Chen P; Chang C
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298144
[TBL] [Abstract][Full Text] [Related]
51. Ginsenoside Rg3 attenuates microglia activation following systemic lipopolysaccharide treatment in mice.
Park SM; Choi MS; Sohn NW; Shin JW
Biol Pharm Bull; 2012; 35(9):1546-52. PubMed ID: 22975507
[TBL] [Abstract][Full Text] [Related]
52. Effect of Panax ginseng combined with Angelica sinensis on the dissolution of ginsenosides and in chemotherapy mice hematopoietic function.
Zheng X; Fu Z; Wang C; Zhang S; Dai M; Cai E; Zhao Y
Bioorg Med Chem; 2019 Sep; 27(18):4211-4218. PubMed ID: 31395508
[TBL] [Abstract][Full Text] [Related]
53. A Review of Neuroprotective Effects and Mechanisms of Ginsenosides From Panax Ginseng in Treating Ischemic Stroke.
Zhao A; Liu N; Yao M; Zhang Y; Yao Z; Feng Y; Liu J; Zhou G
Front Pharmacol; 2022; 13():946752. PubMed ID: 35873557
[TBL] [Abstract][Full Text] [Related]
54. Ginseng under forest exerts stronger anti-aging effects compared to garden ginseng probably via regulating PI3K/AKT/mTOR pathway, SIRT1/NF-κB pathway and intestinal flora.
Hao M; Ding C; Peng X; Chen H; Dong L; Zhang Y; Chen X; Liu W; Luo Y
Phytomedicine; 2022 Oct; 105():154365. PubMed ID: 35930860
[TBL] [Abstract][Full Text] [Related]
55. Peripheral anti-inflammatory effects explain the ginsenosides paradox between poor brain distribution and anti-depression efficacy.
Kang A; Hao H; Zheng X; Liang Y; Xie Y; Xie T; Dai C; Zhao Q; Wu X; Xie L; Wang G
J Neuroinflammation; 2011 Aug; 8():100. PubMed ID: 21843370
[TBL] [Abstract][Full Text] [Related]
56. Pharmacological Efficacy of Ginseng against Respiratory Tract Infections.
Alsayari A; Muhsinah AB; Almaghaslah D; Annadurai S; Wahab S
Molecules; 2021 Jul; 26(13):. PubMed ID: 34279434
[TBL] [Abstract][Full Text] [Related]
57. Anti-inflammatory effects of vina-ginsenoside R2 and majonoside R2 isolated from Panax vietnamensis and their metabolites in lipopolysaccharide-stimulated macrophages.
Jeong JJ; Van Le TH; Lee SY; Eun SH; Nguyen MD; Park JH; Kim DH
Int Immunopharmacol; 2015 Sep; 28(1):700-6. PubMed ID: 26256699
[TBL] [Abstract][Full Text] [Related]
58. Ginseng pharmacology: multiple constituents and multiple actions.
Attele AS; Wu JA; Yuan CS
Biochem Pharmacol; 1999 Dec; 58(11):1685-93. PubMed ID: 10571242
[TBL] [Abstract][Full Text] [Related]
59. Suppression of Hepatic Cyp1a2 by Total Ginsenosides in Lipopolysaccharide-Treated Mice and Primary Mouse Hepatocytes.
Sun H; Yan Y; Xu C; Wan H; Liu D
J Agric Food Chem; 2016 Mar; 64(11):2386-93. PubMed ID: 26923348
[TBL] [Abstract][Full Text] [Related]
60. Ginsenosides: are any of them candidates for drugs acting on the central nervous system?
Nah SY; Kim DH; Rhim H
CNS Drug Rev; 2007; 13(4):381-404. PubMed ID: 18078425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
